These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 20453808)

  • 21. The timing of thrombolysis for strokes complicating cardiac catheterization.
    De Marco F; Routledge H; Lefèvre T
    J Am Coll Cardiol; 2008 Jul; 52(4):317; author reply 317-8. PubMed ID: 18634993
    [No Abstract]   [Full Text] [Related]  

  • 22. Intravitreal tissue plasminogen activator for the treatment of central retinal vein occlusion.
    Weizer JS; Fekrat S
    Ophthalmic Surg Lasers Imaging; 2003; 34(4):350-2. PubMed ID: 12875471
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of surgical treatments for central retinal vein occlusion; RON vs. cannulation of tissue plasminogen activator into the retinal vein.
    Yamamoto T; Kamei M; Sakaguchi H; Oshima Y; Ikuno Y; Gomi F; Ohji M; Tano Y
    Retina; 2009 Sep; 29(8):1167-74. PubMed ID: 19734765
    [TBL] [Abstract][Full Text] [Related]  

  • 24. How should intravenous thrombolytic agents for acute myocardial infarction be selected?
    Topol EJ
    Cardiovasc Clin; 1990; 21(1):57-75; discussion 76-8. PubMed ID: 2143103
    [No Abstract]   [Full Text] [Related]  

  • 25. [Local intra-arterial thrombolysis in acute ischemia of an extremity].
    Enevoldsen MT; Rørdam P; Schroeder TV
    Ugeskr Laeger; 1996 Sep; 158(36):5011-4. PubMed ID: 8928238
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravenous thrombolysis with low-dose recombinant tissue plasminogen activator in central retinal artery occlusion.
    Hattenbach LO; Kuhli-Hattenbach C; Scharrer I; Baatz H
    Am J Ophthalmol; 2008 Nov; 146(5):700-6. PubMed ID: 18718570
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravitreal tissue plasminogen activator for acute central retinal vein occlusion.
    Lahey JM; Fong DS; Kearney J
    Ophthalmic Surg Lasers; 1999 Jun; 30(6):427-34. PubMed ID: 10392729
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Splenic and superior mesenteric artery thrombolytic infusion therapy for acute portal and mesenteric vein thrombosis.
    Safieddine N; Mamazza J; Common A; Prabhudesai V
    Can J Surg; 2007 Feb; 50(1):68-9. PubMed ID: 17391622
    [No Abstract]   [Full Text] [Related]  

  • 29. Surgical treatment of central retinal vein occlusion.
    Berker N; Batman C
    Acta Ophthalmol; 2008 May; 86(3):245-52. PubMed ID: 18494725
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Upper airway obstruction by angioedema following thrombolytic therapy with recombinant tissue plasminogen activator].
    García-Jiménez A; Iriarte Sotés P; Fernández González CJ; Garrote Freire A; González Tutor J
    An Med Interna; 2003 Mar; 20(3):163-4. PubMed ID: 12756909
    [No Abstract]   [Full Text] [Related]  

  • 31. [Thrombolysis in stroke--results of the ECASS study (European Cooperative Acute Stroke Study)].
    Nervenarzt; 1995 Aug; 66(8 Suppl):1-8. PubMed ID: 9131091
    [No Abstract]   [Full Text] [Related]  

  • 32. Surgical treatments of central retinal vein occlusion.
    Parodi MB; Lanzetta P; Guarnaccia G; Friberg T
    Semin Ophthalmol; 2003 Sep; 18(3):142-6. PubMed ID: 15513475
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Thrombolytic therapy with recombinant tissue-type plasminogen activator in patients with branch or central vein occlusion of the retina].
    Kreutzer A; Brunner R; Schäfer HJ; Sickel W; Auel H; Hossmann V
    Fortschr Ophthalmol; 1988; 85(5):511-3. PubMed ID: 3147230
    [No Abstract]   [Full Text] [Related]  

  • 34. Retinal arterial occlusion with LIF using rTPA.
    Hayreh SS
    Ophthalmology; 1999 Jul; 106(7):1236-9. PubMed ID: 10406599
    [No Abstract]   [Full Text] [Related]  

  • 35. [Treatment trials of plasminogen activator (rt-PA) in central vein thrombosis of the retina].
    Reim M; Bertram B; Wolf S
    Klin Wochenschr; 1988; 66 Suppl 12():143-9. PubMed ID: 3126343
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The rationale of retinal endovascular fibrinolysis in the treatment of retinal vein occlusion: from experimental data to clinical application.
    Pournaras CJ; Petropoulos IK; Pournaras JA; Stangos AN; Gilodi N; Rungger-Brändle E
    Retina; 2012 Sep; 32(8):1566-73. PubMed ID: 22466460
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Catheter-directed thrombolysis in a patient with purpura fulminans.
    Jones RG; Gardner GP; Morris ME
    Am Surg; 2012 Nov; 78(11):E448-9. PubMed ID: 23089413
    [No Abstract]   [Full Text] [Related]  

  • 38. Thrombolysis, community hospitals, and primary stroke center.
    Jeng JS
    Acta Neurol Taiwan; 2009 Mar; 18(1):1-2. PubMed ID: 19537567
    [No Abstract]   [Full Text] [Related]  

  • 39. [The characteristics of postinfarct stenocardia and the recurrence of a myocardial infarct after thrombolytic therapy].
    Chernetsov VA
    Voen Med Zh; 1998 Sep; 319(9):59-63. PubMed ID: 9817019
    [No Abstract]   [Full Text] [Related]  

  • 40. [New strategies and perspectives in thrombolytic therapy].
    Bode C; Kübler W
    Internist (Berl); 1992 Apr; 33(4):258-64. PubMed ID: 1612850
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.